How many capsules does a box of Opicapone capsules have?

The number of Opicapone capsules in a box is not fixed. It depends on the production specifications of the pharmaceutical company and the settings of the drug packaging. Generally speaking, the packaging specifications of Opicapone capsules can include a variety of different options such as 30 capsules, 60 capsules or 90 capsules. The specific number of pills will be clearly marked on the drug's instructions or box, so patients can check this information carefully when purchasing.

Opicapone is a catechol-O-methyltransferase (COMT), which is mainly used as an auxiliary treatment for patients with Parkinson's disease who are taking levodopa or carbidopa and are in the "off" phase. This drug reduces the conversion rate of levodopa to 3-O-carbidopa, thereby prolonging the clinical efficacy of levodopa and improving the phenomenon of drug efficacy decline. The recommended dose of Opicapone is usually 50 mg taken once daily at bedtime. However, in patients with moderate hepatic impairment, the recommended dose may be adjusted to 25 mg.

In the market, Opicapone capsules produced by different pharmaceutical companies may have different packaging specifications and prices. For example, the European version of Opicapone is available in 50mg*90 capsules, or other versions are available in 50mg*30 capsules and 25mg*30 capsules. The prices of these different strengths of drugs will also vary, and the specific prices may vary due to exchange rates, market demand, sales channels and pharmacies.

The drug Opicapone has not yet been launched in China, so it is not included in medical insurance. This will undoubtedly increase the financial burden on patients who need to use this drug. However, in Europe, the original drug of Opicapone is already on the market, and each box of 90 50 mg pills sells for about more than 4,000 yuan (the price may change due to exchange rates). There are currently no generic versions of Opicapone on the market, which limits patient options. I hope to find more ways to help patients reduce their burden in the future.